Biochemical and Structural Evaluation of Highly Selective 2-Arylbenzoxazole-Based Transthyretin Amyloidogenesis Inhibitors
摘要:
To develop potent transthyretin (TTR) amyloidogenesis inhibitors that also display high binding selectivity in blood, it proves useful to systematically optimize each of the three substructural elements that comprise a typical inhibitor: the two aryl rings and the linker joining them. In the first study, described herein, structural modifications to one aryl ring were evaluated by screening a library of 2-arylbenzoxazoles bearing thyroid hormone-like aryl substituents on the 2-aryl ring. Several potent and highly selective amyloidogenesis inhibitors were identified that exhibit minimal thyroid hormone nuclear receptor and COX-1 binding. High resolution crystal structures (1.3-1.5 angstrom) of three inhibitors (2f, 4f, and 4d) in complex with TTR were obtained to characterize their binding orientation. Collectively, the results demonstrate that thyroid hormone-like substitution patterns on one aryl ring lead to potent and highly selective TTR amyloidogenesis inhibitors that lack undesirable thyroid hormone receptor or COX-1 binding.
Biochemical and Structural Evaluation of Highly Selective 2-Arylbenzoxazole-Based Transthyretin Amyloidogenesis Inhibitors
摘要:
To develop potent transthyretin (TTR) amyloidogenesis inhibitors that also display high binding selectivity in blood, it proves useful to systematically optimize each of the three substructural elements that comprise a typical inhibitor: the two aryl rings and the linker joining them. In the first study, described herein, structural modifications to one aryl ring were evaluated by screening a library of 2-arylbenzoxazoles bearing thyroid hormone-like aryl substituents on the 2-aryl ring. Several potent and highly selective amyloidogenesis inhibitors were identified that exhibit minimal thyroid hormone nuclear receptor and COX-1 binding. High resolution crystal structures (1.3-1.5 angstrom) of three inhibitors (2f, 4f, and 4d) in complex with TTR were obtained to characterize their binding orientation. Collectively, the results demonstrate that thyroid hormone-like substitution patterns on one aryl ring lead to potent and highly selective TTR amyloidogenesis inhibitors that lack undesirable thyroid hormone receptor or COX-1 binding.
Palladium-Catalyzed Direct Arylations of Heteroarenes with Tosylates and Mesylates
作者:Lutz Ackermann、Andreas Althammer、Sabine Fenner
DOI:10.1002/anie.200804517
日期:2009.1
A toss up: A highly active palladium complex enabled the first directarylation of heteroarenes through CH bond functionalization using tosylates or mesylates as electrophiles with ample scope.
An efficient magnetic copper ferrite nanoparticle: for one pot synthesis of 2-substituted benzoxazole via redox reactions
作者:Sachin A. Sarode、Jeevan M. Bhojane、Jayashree M. Nagarkar
DOI:10.1016/j.tetlet.2014.11.065
日期:2015.1
A new, green and sustainable approach for the synthesis of 2-substituted benzoxazole by using a one pot redox cascade condensation reaction of benzyl amine and 2-nitro phenol, catalysed by Cu Ferrite NPs is reported. Cu Ferrite NPs are magnetically separable, air stable and can be recycled up to fifth cycle without a significant loss in catalytic activity. The catalyst is characterised by FEG-SEM, TEM, EDAX and XRD. (C) 2014 Elsevier Ltd. All rights reserved.
Sequential one-pot synthesis of benzoxazoles from aryl bromides: successive palladium- and copper-catalyzed reactions
A convenient one-pot process has been developed for the synthesis of benzoxazoles. Starting from aryl bromides and 1,2-dibromobenzenes palladium-catalyzed aminocarbonylation and subsequent copper-catalyzed coupling reaction gave a variety of substituted benzoxazoles in moderate to good yields. (C) 2013 Elsevier Ltd. All rights reserved.
Biochemical and Structural Evaluation of Highly Selective 2-Arylbenzoxazole-Based Transthyretin Amyloidogenesis Inhibitors
作者:Steven M. Johnson、Stephen Connelly、Ian A. Wilson、Jeffery W. Kelly
DOI:10.1021/jm0708735
日期:2008.1.1
To develop potent transthyretin (TTR) amyloidogenesis inhibitors that also display high binding selectivity in blood, it proves useful to systematically optimize each of the three substructural elements that comprise a typical inhibitor: the two aryl rings and the linker joining them. In the first study, described herein, structural modifications to one aryl ring were evaluated by screening a library of 2-arylbenzoxazoles bearing thyroid hormone-like aryl substituents on the 2-aryl ring. Several potent and highly selective amyloidogenesis inhibitors were identified that exhibit minimal thyroid hormone nuclear receptor and COX-1 binding. High resolution crystal structures (1.3-1.5 angstrom) of three inhibitors (2f, 4f, and 4d) in complex with TTR were obtained to characterize their binding orientation. Collectively, the results demonstrate that thyroid hormone-like substitution patterns on one aryl ring lead to potent and highly selective TTR amyloidogenesis inhibitors that lack undesirable thyroid hormone receptor or COX-1 binding.